Scarica l'app Stockscreener
4.91
3.91%
-0.20
Dopo l'orario di chiusura:
4.93
0.02
+0.41%
Precedente Chiudi:
$5.11
Aprire:
$5.04
Volume 24 ore:
10.46M
Relative Volume:
1.74
Capitalizzazione di mercato:
$871.39M
Reddito:
$2.54B
Utile/perdita netta:
$-207.36M
Rapporto P/E:
-4.1261
EPS:
-1.19
Flusso di cassa netto:
$151.25M
1 W Prestazione:
-14.46%
1M Prestazione:
-30.35%
6M Prestazione:
-29.56%
1 anno Prestazione:
-52.79%
Intervallo 1D:
$4.86
$5.18
Intervallo di 1 settimana:
$4.86
$5.765
Portata 52W:
$4.86
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
155 E 44TH STREET, NEW YORK, NY
Confronta TDOC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
4.91 | 906.89M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
190.69 | 31.36B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.55 | 9.96B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
81.34 | 7.02B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.28 | 7.04B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
DOCS
Doximity Inc
|
35.25 | 6.56B | 550.17M | 201.35M | 232.07M | 1.00 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-07-25 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Jim Cramer on Teladoc: "I Don't See Any Reason to Own It" - Finviz
Jim Cramer on Teladoc: “I Don’t See Any Reason to Own It” - Insider Monkey
Lacklustre Performance Is Driving Teladoc Health, Inc.'s (NYSE:TDOC) 28% Price Drop - 富途牛牛
Teladoc Health, Inc.'s (NYSE:TDOC) 28% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st
Teladoc Health, Inc. (TDOC) Investor Outlook: Is The 66% Upside Within Reach? - DirectorsTalk Interviews
The Truth About Teladoc Health Inc: Is TDOC’s Telehealth Empire Still Worth Your Money? - AD HOC NEWS
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance Singapore
Teladoc Health (NYSE:TDOC) Hits New 12-Month LowHere's Why - MarketBeat
(TDOC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
A Look At Teladoc Health’s Valuation As Medicare Telehealth Policy And Options Activity Drive Uncertainty - Sahm
What are Teladoc Health Inc.’s earnings expectationsJuly 2025 Volume & Low Drawdown Investment Strategies - mfd.ru
Chuck Divita on why 2026 is Teladoc’s ‘execution year’ - Healthcare Dive
Teladoc hits all-time low as a risky pattern points to a deeper dive - TradingView
Published on: 2026-01-29 14:18:31 - baoquankhu1.vn
Teleoncology Market to Reach US$ 15.03 Billion by 2032 at 15.7% - openPR.com
A Look At Teladoc Health (TDOC) Valuation As Medicare And BetterHelp Concerns Drive Volatility - Yahoo Finance
Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? - The Globe and Mail
Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? - The Motley Fool
Medicare Telehealth Uncertainty And BetterHelp Weakness Test Teladoc Valuation - Sahm
Is Teladoc Health (TDOC) A Potential Opportunity After Prolonged Share Price Weakness - Yahoo Finance
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Why Teladoc (TDOC) Shares Are Plunging Today - Finviz
Teladoc Health (NYSE:TDOC) Hits New 1-Year LowShould You Sell? - MarketBeat
Are Telehealth Stocks Set to Tumble in 2026? - The Globe and Mail
Teladoc stock hits 52-week low at 6.03 USD - Investing.com
Teladoc price target lowered to $7 from $7.50 at BofA Securities - Investing.com Canada
Teladoc (TDOC) Sees Surge in Call Option Activity - GuruFocus
Teladoc offers free non-emergency care for Texans impacted by winter storm - CW33.com
Analyst Calls: What is the target price for Teladoc Health Inc stockQuarterly Market Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Teladoc’s Data-Driven 24/7 Care Upgrade Could Be A Game Changer For Teladoc Health (TDOC) - Sahm
Assessing Teladoc Health (TDOC) Valuation As Investor Caution Grows Despite Product Updates - Sahm
Is Teladoc’s Expanded 24/7 Care Data Strategy a Durable Edge in Virtual Care Competition (TDOC)? - Yahoo Finance
2 Beaten-Down Stocks That Could Sink Even More in 2026 - Finviz
Is Teladoc (TDOC) Now Offering Value After Multi‑Year Share Price Declines - Sahm
Sarepta and Teladoc Face Major Challenges, Stock Outlook Dim - Intellectia AI
Sarepta Therapeutics and Teladoc Health Face Major Challenges, 2026 Outlook Dismal - Intellectia AI
Teladoc Health Sees Unusually Large Options Volume (NYSE:TDOC) - MarketBeat
Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade) (NYSE:TDOC) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Teladoc (TDOC) and Immunome (IMNM) - The Globe and Mail
Teladoc Health shares tumble for seven consecutive sessions - MSN
Teladoc Health (TDOC) Faces Decline Amid Analyst Optimism - GuruFocus
Teladoc Health (TDOC) Shares Drop for Seven Consecutive Sessions, Losing Nearly 16% - Intellectia AI
Teladoc and EverQuote Shares Plummet, What You Need To Know - Finviz
(TDOC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
3 Reasons to Avoid TDOC and 1 Stock to Buy Instead - Finviz
Hims & Hers Expands Platform-Led Access to Digital Healthcare - The Globe and Mail
Analyst Downgrade: Can Teladoc Health Inc beat the S P 500Entry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
Teladoc stock hits 52-week low at $6.34 By Investing.com - Investing.com Nigeria
Aug Movers: What is Teladoc Health Incs TAM Total Addressable MarketWeekly Profit Recap & Real-Time Market Trend Scan - baoquankhu1.vn
Teladoc Health (NYSE:TDOC) Reaches New 52-Week LowTime to Sell? - MarketBeat
Teladoc stock hits 52-week low at $6.34 - Investing.com
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):